|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sharma P: Biology and management of
patients with triple-negative breast cancer. Oncologist.
21:1050–1062. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Foulkes WD, Smith IE and Reis-Filho JS:
Triple-negative breast cancer. N Engl J Med. 363:1938–1948.
2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Reynoso-Noverón N, Villarreal-Garza C,
Soto-Perez-de-Celis E, Arce-Salinas C, Matus-Santos J,
Ramírez-Ugalde MT, Alvarado-Miranda A, Cabrera-Galeana P,
Meneses-García A, Lara-Medina F, et al: Clinical and
epidemiological profile of breast cancer in mexico: Results of the
seguro popular. J Glob Oncol. 3:757–764. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lara-Medina F, Pérez-Sánchez V,
Saavedra-Pérez D, Blake-Cerda M, Arce C, Motola-Kuba D,
Villarreal-Garza C, González-Angulo AM, Bargalló E, Aguilar JL, et
al: Triple-negative breast cancer in Hispanic patients. Cancer.
117:3658–3669. 2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
de Ruijter TC, Veeck J, de Hoon JPJ, van
Engeland M and Tjan-Heijnen VC: Characteristics of triple-negative
breast cancer. J Cancer Res Clin Oncol. 137:183–192.
2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kennecke H, Yerushalmi R, Woods R, Cheang
MC, Voduc D, Speers CH, Nielsen TO and Gelmon K: Metastatic
behavior of breast cancer subtypes. J Clin Oncol. 28:3271–3277.
2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Li X, Yang J, Peng L, Sahin AA, Huo L,
Ward KC, O'Regan R, Torres MA and Meisel JL: Triple-negative breast
cancer has worse overall survival and cause-specific survival than
non-triple-negative breast cancer. Breast Cancer Res Treat.
161:279–287. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Martin AM, Cagney DN, Catalano PJ, Warren
LE, Bellon JR, Punglia RS, Claus EB, Lee EQ, Wen PY, Haas-Kogan DA,
et al: Brain metastases in newly diagnosed breast cancer: A
population-based study. JAMA Oncol. 3:1069–1077. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Xiao W, Zheng S, Yang A, Zhang X, Zou Y,
Tang H and Xie X: Breast cancer subtypes and the risk of distant
metastasis at initial diagnosis: A population-based study. Cancer
Manag Res Volume. 10:5329–5338. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ignatov A, Eggemann H, Burger E and
Ignatov T: Patterns of breast cancer relapse in accordance to
biological subtype. J Cancer Res Clin Oncol. 144:1347–1355.
2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Jin J, Gao Y, Zhang J, Wang L, Wang B, Cao
J, Shao Z and Wang Z: Incidence, pattern and prognosis of brain
metastases in patients with metastatic triple negative breast
cancer. BMC Cancer. 18(446)2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Rostami R, Mittal S, Rostami P, Tavassoli
F and Jabbari B: Brain metastasis in breast cancer: A comprehensive
literature review. J Neurooncol. 127:407–414. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kim YJ, Kim JS and Kim IA: Molecular
subtype predicts incidence and prognosis of brain metastasis from
breast cancer in SEER database. J Cancer Res Clin Oncol.
144:1803–1816. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Heitz F, Harter P, Lueck HJ,
Fissler-Eckhoff A, Lorenz-Salehi F, Scheil-Bertram S, Traut A and
du Bois A: Triple-negative and HER2-overexpressing breast cancers
exhibit an elevated risk and an earlier occurrence of cerebral
metastases. Eur J Cancer. 45:2792–2798. 2009.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Minami CA, Chung DU and Chang HR:
Management options in triple-negative breast cancer. Breast Cancer
(Auckl). 5:175–199. 2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kennedy BM and Harris RE: Cyclooxygenase
and lipoxygenase gene expression in the inflammogenesis of breast
cancer. Inflammopharmacology. 26:909–923. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lehmann BD, Bauer JA, Chen X, Sanders ME,
Chakravarthy AB, Shyr Y and Pietenpol JA: Identification of human
triple-negative breast cancer subtypes and preclinical models for
selection of targeted therapies. J Clin Invest. 121:2750–2767.
2011.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Masuda H, Baggerly KA, Wang Y, Zhang Y,
Gonzalez-Angulo AM, Meric-Bernstam F, Valero V, Lehmann BD,
Pietenpol JA, Hortobagyi GN, et al: Differential response to
neoadjuvant chemotherapy among 7 triple-negative breast cancer
molecular subtypes. Clin Cancer Res. 19(5533)2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hines LM, Risendal B, Byers T, Mengshol S,
Lowery J and Singh M: Ethnic disparities in breast tumor phenotypic
subtypes in hispanic and non-hispanic white women. J Womens Health.
20:1543–1550. 2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Yin L, Duan JJ, Bian XW and Yu S:
Triple-negative breast cancer molecular subtyping and treatment
progress. Breast Cancer Res. 22(61)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Fitzgibbons PL, Dillon DA, Alsabeh R,
Berman MA, Hayes DF, Hicks DG, Hughes KS and Nofech-Mozes S:
Template for reporting results of biomarker testing of specimens
from patients with carcinoma of the breast. Arch Pathol Lab Med.
138:595–601. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Rodríguez-Bautista R, Caro-Sánchez CH,
Cabrera-Galeana P, Alanis-Funes GJ, Gutierrez-Millán E, Ávila-Ríos
S, Matías-Florentino M, Reyes-Terán G, Díaz-Chávez J,
Villarreal-Garza C, et al: Immune Milieu and genomic alterations
set the triple-negative breast cancer immunomodulatory subtype
tumor behavior. Cancers (Basel). 13(6256)2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
RStudio Team: RStudio: Integrated
Development of R., 2021.
|
|
25
|
Marini F, Linke J and Binder H: Ideal: An
R/Bioconductor package for Interactive differential expression
analysis. BMC Bioinformatics. 21(565)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Bolstad BM, Irizarry RA, Åstrand M and
Speed TP: A comparison of normalization methods for high density
oligonucleotide array data based on variance and bias.
Bioinformatics. 19:185–193. 2003.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Irizarry RA, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP:
Exploration, normalization, and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Banerji S, Cibulskis K, Rangel-Escareno C,
Brown KK, Carter SL, Frederick AM, Lawrence MS, Sivachenko AY,
Sougnez C, Zou L, et al: Sequence analysis of mutations and
translocations across breast cancer subtypes. Nature. 486:405–409.
2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Johnson WE, Li C and Rabinovic A:
Adjusting batch effects in microarray expression data using
empirical Bayes methods. Biostatistics. 8:118–127. 2007.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Parker JS, Mullins M, Cheang MCU, Leung S,
Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, et al:
Supervised risk predictor of breast cancer based on intrinsic
subtypes. J Clin Oncol. 27:1160–1167. 2009.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Bareche Y, Venet D, Ignatiadis M, Aftimos
P, Piccart M, Rothe F and Sotiriou C: Unravelling triple-negative
breast cancer molecular heterogeneity using an integrative
multiomic analysis. Ann Oncol. 29:895–902. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Hubalek M, Czech T and Müller H:
Biological subtypes of triple-negative breast cancer. Breast Care.
12:8–14. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Brosnan EM and Anders CK: Understanding
patterns of brain metastasis in breast cancer and designing
rational therapeutic strategies. Ann Transl Med. 6:163.
2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Quattrocchi CC, Errante Y, Gaudino C,
Mallio CA, Giona A, Santini D, Tonini G and Zobel BB: Spatial brain
distribution of intra-axial metastatic lesions in breast and lung
cancer patients. J Neurooncol. 110:79–87. 2012.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lv Y, Ma X, Du Y and Feng J: Understanding
patterns of brain metastasis in triple-negative breast cancer and
exploring potential therapeutic targets. Onco Targets Ther.
14:589–607. 2021.PubMed/NCBI View Article : Google Scholar
|
